Compound information
- Natural Products
- ZC518681
- Molecular Formula
- C14H21N3O4S
- Molecular Weight
- 327.125277152 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-pyridylsulfonyl)piperazine-1-carboxylate
- InChI
- InChI=1S/C14H21N3O4S/c1-14(2,3)21-13(18)16-8-10-17(11-9-16)22(19,20)12-4-6-15-7-5-12/h4-7H,8-11H2,1-3H3
- InChI Key
- VWKPIOUCWXYBSO-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(S(=O)(=O)c2ccncc2)CC1
- Source
- ZINC001190853460
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 79.81 Å2 | LogP | 1.027 |
LogS | -1.505 | LogD | 1.996 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.038 | Pgp substrate | 0.065 |
HIA | 0.965 | F20 % | 0.989 |
F30 % | 0.956 | Caco-2 | -4.575 |
MDCK | -4.724 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.669 | PPB | 81.31 |
VD | 1.111 | Fu | 0.311 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.023 | CYP1A2 substrate | 0.406 |
CYP2A6 substrate | 0.658 | CYP2B6 substrate | 0.696 |
CYP2C19 inhibitor | 0.893 | CYP2C19 substrate | 0.764 |
CYP2C8 substrate | 0.573 | CYP2C9 inhibitor | 0.537 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.008 |
CYP2D6 substrate | 0.773 | CYP2E1 substrate | 0.876 |
CYP3A4 inhibitor | 0.211 | CYP3A4 substrate | 0.996 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.643 | CL | 6.498 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.65 | Hepatotoxicity | 0.973 |
Mutagenicity | 0.193 | Rat Oral Acute Toxicity | 0.528 |
FDAMDD | 0.125 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.537 | Eye Corrosion | 0.006 |
Eye Irritation | 0.068 | Respiratory Toxicity | 0.524 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.867 | IGC50 | 2.463 |
LC50FM | 2.01 | LC50DM | 2.71 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.213 | NR-AR-LBD | 0.252 |
NR-AhR | 0.122 | NR-Aromatase | 0.682 |
NR-ER | 0.237 | NR-ER-LBD | 0.361 |
NR-PPAR-gamma | 0.126 | SR-ARE | 0.691 |
SR-ATAD5 | 0.352 | SR-HSE | 0.082 |
SR-MMP | 0.014 | SR-p53 | 0.028 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.